A third dose of vaccine for those 65 and over, but not for the youngest. After a day of debates, the experts of the advisory committee of the United States Medicines Agency (FDA) issued two decisions regarding the injection of a third dose in the United States.
Experts were unanimous on the need for a third dose of the Pfizer vaccine for all Americans aged over 65 or at risk. However, they are against this third injection in the general population. This is a setback for President Joe Biden who wanted to launch a recall campaign.
According to experts, the third injection is necessary for people at high risk of developing a severe form of the disease, six months after the second dose. They also believe that caregivers should be included among these “high risk” people.
Experts worried about the injection of the 3rd dose to all Americans
But this panel also expressed its concerns as to the possible side effects that an additional dose of the vaccine would cause if it were administered to the entire population, especially among the youngest. She is thus opposed to the Biden administration’s major recall campaign aimed at adults. Scientists notably mentioned concerns about the risks of myocarditis, an inflammation of the heart muscle, in young adolescents and adults.
The recommendations of this committee of experts are not binding, but it is very rare that they are not respected by the authorities. President Joe Biden’s administration announced in August the launch of an anti-Covid vaccine booster campaign for all American adults having received their second dose eight months previously, starting September 20. But this decision had taken many experts by surprise, inviting mistrust even in the ranks of the FDA, who had published a document tinged with caution before the meeting on Friday, September 17.
–
– .
